N6-methyladenosine (m6A) is a dynamic, reversible post-transcriptional modification, and
the most common internal modification of eukaryotic messenger RNA (mRNA) …

Background: Bladder cancer (BLCA) is highly heterogeneous with distinct molecular
subtypes. This research aimed to investigate the heterogeneity of different molecular …

Purpose Disulfidptosis is a novel type of cell death induced by disulphide stress that
depends on the accumulation of cystine disulphide, causing cytotoxicity and triggering cell …

Background An improved risk assessment of patients with bladder cancer (BC) is important
to optimize clinical management. Objective To identify whether immune cell subpopulations …

Bladder cancer is one of the most common malignant tumors of the urinary system that
seriously threatens the health of a population. In recent years, the application of …

Background: Glioblastoma multiforme (GBM) is the most common and invasive primary
central nervous system tumor. The prognosis after surgery, radiation and chemotherapy is …

Urothelial bladder cancer (UBC) is a global challenge of public health with limited
therapeutic options. Although the emergence of cancer immunotherapy, most notably …

Objective The malignant progression from non-muscle-invasive bladder cancer (NMIBC) to
muscle-invasive bladder cancer (MIBC) is common and has detrimental effect on patients …

Background: Bladder cancer (BLCA) is the major tumor of the urinary system, and immune-
related genes (IRGs) contribute significantly to its initiation and prognosis. Results: A total of …

Background: Bladder cancer is the most cost-intensive cancer due to high recurrence rates
and long follow-up times. Bladder cancer organoids were considered interesting tools for …